Screener
WatchList
Alerts
Calendar
Signals
M&A
Guide
Pricing
Sign In
Home
›
Screener
›
DYAI
›
Profile
F
10/100
Dyadic International, Inc.
DYAI
RNA Therapy
← Signals View
Not financial advice. BiotechSign profiles are automatically assembled from public-source records (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-06-07
2026-09-03
Signal Summary
PDUFA Dates
0
Insider Filings
0
Clinical Trials
1
Sector Peers (RNA Therapy)
TRDA
Entrada Therapeutics
F
NAII
Natural Alternatives International, Inc.
F
ARCT
Arctus Therapeutics
F
SSII
SS Innovations International Inc.
F
MGIH
Millennium Group International Holdings Limited
F
Show all 8 peers →
Data Provenance
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR